D-0462-2022 Class I Terminated

Recalled by Mylan Pharmaceuticals Inc — Morgantown, WV

Recall Details

Product Type
Drugs
Report Date
January 26, 2022
Initiation Date
January 5, 2022
Termination Date
January 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
73,175 prefilled pens

Product Description

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.

Reason for Recall

Labeling: Missing Label: label missing from some Semglee prefilled pens.

Distribution Pattern

Nationwide in the USA and Thailand.

Code Information

Batch # BF20003118, Exp. August 2022